BioCentury
ARTICLE | Company News

Meda denies takeover bid

July 28, 2011 12:31 AM UTC

Meda AB (SSE:MEDAA) issued a statement Wednesday that it has not received a takeover approach of the kind described late Tuesday in an article in The Wall Street Journal. The article said partner Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) made a takeover approach. Valeant could not be reached for comment. Meda was up SEK4.75 to SEK75.80 on Wednesday. Valeant was up C$0.27 to C$52.75. In New York, the stock was down $0.04 to $55.68 on Wednesday. ...